De Miguel C, Pollock DM, Pollock JS. Endothelium-derived ET-1 and the development of renal injury. Am J Physiol Regul Integr Comp Physiol 309: R1071-R1073, 2015. First published May 20, 2015 doi:10.1152/ajpregu.00142.2015.-The role of the vasoactive peptide endothelin-1 (ET-1) in renal injury is not fully understood. In this review, we examine the genetic models available to understand the autocrine/paracrine mechanisms by which ET-1 leads to renal injury and propose the working hypothesis that endothelium-derived ET-1 induces renal injury by initiating renal tubular apoptosis in a paracrine manner.
endothelin-1; apoptosis; renal injury ENDOTHELIN-1 (ET-1) is an endogenous 21 amino acid peptide that has powerful vasoactive properties. ET-1 is produced by many cell types including endothelial cells (40) , cardiomyocytes (36) , mesangial cells (31) , and different segments of the nephron, especially collecting ducts (22) . Increased activity of the ET-1 system has been described in several cardiovascular and renal diseases (25, 28) . ET-1 stimulates two G proteincoupled receptor subtypes, ET A and ET B receptors, with the same affinity for both receptors (7) . Activation of each receptor subtype leads to different, and often opposite, physiological and pathophysiological results (3) . Renal cortical and inner medullary tubules are rich in ET B receptors, whereas outer medullary tubules express both ET A and ET B receptors. Overactivation of the renal ET A pathway leads to hypertrophy, inflammation, and fibrosis. Actions of the ET B pathway promote clearance of ET-1 from circulation, stimulation of nitric oxide, and/or prostacyclin release, as well as increased sodium and water excretion (23) . Several cell-type-specific endothelin pathway knockout mouse models and an ET B receptor-deficient rat model facilitate in-depth investigations into the activation of cellular source(s) and actions of ET-1. This review highlights the rationale for the use of genetic rodent models to elucidate the autocrine and/or paracrine mechanisms of ET-1-dependent development of renal apoptosis and injury. Based on the literature and our own preliminary findings, studying tunicamycin-induced renal apoptosis in two ET-1 genetic rodent models provides rationale for a working hypothesis that endothelium-derived ET-1 induces renal tubular apoptosis by a paracrine mechanism.
ET-1 Pathway, Apoptosis, and Renal Injury
Renal injury is preceded by tubular apoptosis and loss of nephrons (26) . Apoptotic cell death is characterized by a series of changes in cellular morphology, such as shrinkage of the cell membrane, condensation of nuclear chromatin, cellular fragmentation, and engulfment of the apoptotic bodies by neighboring cells (21) . Different vasoactive peptides have been implicated in the regulation of cellular apoptosis; however, contradictory reports in the literature do not provide a clear role of ET-1 in apoptosis and renal injury. Some studies indicate that ET-1 attenuates apoptosis in vascular smooth muscle cells (39) , endothelial cells (11) , and fibroblasts (33), whereas others describe pro-apoptotic effects of ET-1 in vascular smooth cells (5) or different areas of the kidney such as glomeruli, tubular cells, and interstitial cells (17) .
Part of the confusion regarding the role of the endothelin pathway in apoptosis may be related to the conditions under study and the ET receptors involved. Several publications report that ET A receptor activation promotes cell proliferation and cell survival in a rat model of polycystic kidney disease (PKD) (16) during kidney development (41) , in vascular smooth muscle cells (34) , or in cardiomyocytes (27) , whereas others describe pro-apoptotic effects of the ET A receptor in a model of chronic renovascular disease (19) . Furthermore, ET Bselective agonists decreased apoptosis in rat endothelial cells (33) and ET B antagonists lead to increased apoptosis in rat and human endothelial cells (11, 32) . Cancer studies show that activation of the ET B receptor is considered a survival mechanism (24) , whereas the inhibition or loss of the ET B receptor is protective against apoptosis in renal tubular cells of a mouse model of PKD (6) or neurons subjected to hypoxia-ischemia (35) . It is clear from all these reports that the ET pathway is involved and that a better understanding of the mechanisms by which ET-1 leads to renal injury, especially renal apoptosis, is needed. Thus utilizing a variety of genetic models would be advantageous for the study of ET-1-dependent mechanisms in renal apoptosis and injury.
Genetic Rodent Models: ET-1/ET A Pathway Versus ET-1/ ET B Pathway
To (38) , and stimulates glomerular formation of reactive oxygen species in response to highsalt diet or hypoxia (15) .
Several genetic rodent models were generated to better understand the differential roles of the ET A and ET B receptors. For instance, rats without a functional ET B receptor display endothelial dysfunction (30) and salt-sensitive hypertension (12) via overactivation of ET A receptors (29) . In addition, Kohan et al. demonstrated that collecting duct-specific knockout of ET-1 or the ET B receptor, but not the ET A receptor, leads to hypertension, sodium retention (1), and decreased plasma vasopressin levels (13) . These studies highlight the importance of the ET-1/ET B pathway in the collecting duct as a physiological regulator of ENaC activity (4, 14) and systemic blood pressure. Interestingly, specific vascular smooth muscle disruption of the ET A receptor in mice leads to reduced blood pressure responses to high-salt diet and reduced vascular reactivity, highlighting the important role of this receptor in mediating the ET-1-induced vasoconstriction (10) . An important question is the degree to which the loss of ET B receptor function results in elevated ET A -dependent effects that are unopposed.
Working Hypothesis: Endothelium-Derived ET-1 Mediates Renal Tubular Apoptosis
ET-1 is released from the basolateral cellular side highlighting the role of this peptide as an autocrine/paracrine factor (37) . Recently, Widyantoro et al. (38) reported that endothelium-derived ET-1 is necessary for the development of cardiac fibrosis during diabetes, further emphasizing the paracrine actions of ET-1 and its role in tissue damage. Preliminary evidence from our laboratory show that control mice treated overnight with tunicamycin have significant levels of apoptosis in the outer medullary tubules, but not in renal vessels (9) . We found that the outer medullary tubules of VEET KO mice are protected against the development of apoptosis in response to tunicamycin (9) , indicating a role for the pro-apoptotic effects of endothelium-derived ET-1 on kidney tubular cells in a paracrine manner. Moreover, given that the outer medulla expresses ET A receptors, these studies suggest that the ET A receptor is pro-apoptotic in this particular rodent model. Tunicamycin can induce endoplasmic reticulum (ER) stress-and mitochondrial-mediated apoptosis (18) , although the direct involvement of ET-1 was not tested in this study. Using the ET B -deficient rat as an experimental model, our group previously reported that pharmacological blockade of the ET A receptor ameliorates tunicamycin-induced renal ER stress and apoptosis in transgenic control rats, while failing to do so in the ET B -deficient rats (8) . These results highlight the critical role of ET A receptor activation in renal apoptosis as well as the protective effect of the ET B receptor against tunicamycininduced renal apoptosis. Interestingly, acute treatment with tunicamycin did not alter circulating ET-1 levels. Based on our preliminary results and information from the literature, we propose the working hypothesis that activation of endotheliumderived ET-1 induces renal tubular apoptosis in a paracrine manner (Fig. 1) .
Perspectives and Significance
To test our proposed hypothesis, our laboratory will utilize the VEET KO mouse model with pharmacological blockade of the ET A and ET B receptors to assess the effect on tunicamycininduced renal apoptosis. We will further differentiate between the actions of renal or nonrenal sources of ET-1 in the development of tunicamycin-induced renal apoptosis with renal transplantation studies in flox control and VEET KO mice. The preliminary results and the proposed studies with genetic models will determine the potential therapeutic value of targeting the endothelial ET-1 system to prevent the development of renal injury and apoptosis. 
